Trademark Details For ABIDE (Serial Number 88193779)

Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of treating diseases involving lipid signaling pathways; research and development in pharmacology for the purpose of treating diseases involving the signaling pathways of the central nervous system; medical research for use in treating central nervous system disorders; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; pharmaceutical research in the field of enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases; pharmaceutical research in the fields of immunology, namely, rheumatology, oncology, namely, immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology, namely, fertility, infectiology, namely, virology, ophthalmology, hepatology, neurology, geriatrics, laboratory medicine, clinical diagnostics, genetics and phenomics, pathology and forensics, proteomics, veterinary medicine and diagnostics, and pharmaceutical research tool development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for use in drug development; pharmaceutical research, namely, research relating to enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for improving pharmacological properties; pharmaceutical research, namely, research relating to enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for use in connection with a wide variety of therapeutic areas;